Published in Ter Arkh on January 01, 2003
[Foreign experience in registering and analyzing the poor outcomes of treatment]. Arkh Patol (2009) 0.82
[Relations between ankylosing spondyloarthritis and HLA-B27 in various ethnic groups in Russia]. Ter Arkh (2001) 0.80
[Benign prostate hyperplasia as an age-related problem]. Arkh Patol (2008) 0.79
[Synovial membrane in the early stage of rheumatoid arthritis: clinico-morphological comparisons]. Ter Arkh (2003) 0.78
[Some aspects of pathogenesis of ankylosing spondylitis]. Ter Arkh (2011) 0.78
[Efficacy of colloid bismuth subcitrate (De-Nol) in gastropathies induced by nonsteroid anti-inflammatory drugs: an open controlled 4-week trial]. Ter Arkh (2005) 0.77
[The prevalence of rheumatoid arthritis and the rheumatoid factor in the native inhabitants of northeastern Siberia]. Ter Arkh (1999) 0.77
[Familial systemic scleroderma: a follow-up study of concordant monozygotic twins]. Ter Arkh (1981) 0.76
[The epidemiology of spondyloarthropathies among the native inhabitants of Chukotka. 2. The prevalence of HLA-B27 in the population and among spondyloarthropathy patients]. Ter Arkh (1994) 0.76
[Acute erosive gastropathies]. Arkh Patol (2011) 0.76
[Isolation and characteristics of the DNA of donor and systemic lupus erythematosus patient blood plasma]. Biull Eksp Biol Med (1980) 0.75
[Aseptic bone necrosis in systemic lupus erythematosus and related diseases]. Ter Arkh (1980) 0.75
[Joint syndrome in the early diagnosis of rheumatic diseases in adolescents]. Revmatologiia (Mosk) (1985) 0.75
[The use of a modified Health Assessment Questionnaire for evaluating the effectiveness of therapy at a hospital]. Ter Arkh (1990) 0.75
[Clinico-genetic associations in systemic lupus erythematosus]. Ter Arkh (1981) 0.75
[Trends in the rheumatic diseases morbidity in the Russian Federation population for 1999-2003]. Ter Arkh (2005) 0.75
[Physiology and pathology of the thymus gland]. Akush Ginekol (Mosk) (1987) 0.75
[Primary subacute infectious endocarditis as a manifestation of surgical sepsis]. Ter Arkh (1990) 0.75
[The HLA system and its contribution to the genetics of rheumatic diseases]. Genetika (1986) 0.75
[Pathologicoanatomic evaluation of the sequelae of medical manipulations]. Arkh Patol (1988) 0.75
[Rheumatic diseases in the population of the Russian Federation in the beginning of the XXI century]. Ter Arkh (2007) 0.75
[The control of rheumatism in the 2nd half of the 20th century in Russia]. Ter Arkh (1995) 0.75
[The causes of death of patients with rheumatic diseases in Moscow]. Klin Med (Mosk) (2005) 0.75
[Heterogeneity and polymorphism of the thymus hyperplasia syndrome in children in the first 3 years of life]. Pediatriia (1991) 0.75
[Statistic-mapping modeling of rheumatic diseases prevalence among population of different regions of Russia]. Ter Arkh (2004) 0.75
[Mixed connective tissue disease (a review of the literature)]. Vopr Revm (1980) 0.75
[A systems pathologicoanatomical analysis of the causes of maternal mortality]. Arkh Patol (1999) 0.75
[Primary and secondary (reactive) thymus hyperplasia in cases of sudden death]. Arkh Patol (1984) 0.75
[Syndrome of enlarged thymus gland in children with congenital heart defects]. Arkh Patol (2001) 0.75
[Contribution of V. A. Nasonova, academician of RAMS, to the development of Russian rheumatology]. Vestn Ross Akad Med Nauk (2008) 0.75
[Medico-social problems of chronic articular and spinal diseases]. Ter Arkh (2000) 0.75
[The dynamics of the basic statistical indices of rheumatic diseases in the Russian Federation]. Ter Arkh (1992) 0.75
[Predisposing and manifesting factors in the development of systemic lupus erythematosus]. Sov Med (1978) 0.75
[The 50th anniversary of the Institute of Rheumatology]. Ter Arkh (2008) 0.75
[Antibodies to double-helical RNA and several viruses in medical personnel caring for systemic lupus erythematosus patients]. Vopr Virusol (1979) 0.75
[Acute transverse myelitis in patients with systemic lupus erythematosus]. Ter Arkh (1991) 0.75
[Ways to improve the system of registration of rheumatic diseases]. Revmatologiia (Mosk) (1992) 0.75
[Epithelial tumors of the thymus gland]. Arkh Patol (1996) 0.75
[Myocardial infarct in systemic lupus erythematosus]. Ter Arkh (1979) 0.75
[Experience at cooperation between the Moscow Municipal Center of Pathology Research and the Chair of Pathology of the Russian Medical Academy of Postgraduate Training]. Arkh Patol (1999) 0.75
[Use of modified Stanford Health Assessment Questionnaire in patients with rheumatoid arthritis]. Revmatologiia (Mosk) (1990) 0.75
[Visceral manifestations of glycosphingolipidosis (Fabry's disease)]. Arkh Patol (1987) 0.75
[Congenital hypoplasia of the pancreas with lipomatosis and bone marrow dysfunction (Shwachman syndrome)]. Arkh Patol (1991) 0.75
[Congenital heart block and systemic lupus erythematosus]. Revmatologiia (Mosk) (1984) 0.75
[Malignant carcinoid of the duodenum with polymorphism of the neuroendocrine granules]. Arkh Patol (1984) 0.75
[Role of the Institute of Rheumatology in formation and development of State controlling system of rheumatic diseases]. Vestn Ross Akad Med Nauk (1998) 0.75
[The production of immunomodulating polypeptides by the thymus during its acute (accidental) involution in children]. Arkh Patol (1990) 0.75
[The functional morphology of the thymus in systemic lupus erythematosus and its characteristics during immunodepressive and immunostimulating therapies]. Arkh Patol (1990) 0.75
[The thymo-lymphatic system in congenital thymomegaly (clinico-morphological study)]. Arkh Patol (1988) 0.75
[Systemic lupus erythematosus]. Med Sestra (1984) 0.75
[Thymus gland pathology in myasthenia gravis: cause or consequence?]. Sov Med (1990) 0.75
[Autoimmunization and autoimmune diseases]. Arkh Patol (1992) 0.75
[Eccrine spiradenoma]. Arkh Patol (1999) 0.75
[Evaluation and prognosis of work capacity in rheumatoid arthritis]. Revmatologiia (Mosk) (1990) 0.75
[Rheumatic disease morbidity in the population of Russia at the beginning of the new century]. Ter Arkh (2003) 0.75
[Prognostic factors in systemic lupus erythematosus in adolescents (computer analysis)]. Ter Arkh (1988) 0.75
[New data on thymomegaly as a syndrome of congenital (primary) immunodeficiency]. Arkh Patol (1990) 0.75
[A study of the dynamics of a contingent of patients with rheumatic diseases during ambulatory care (based on data from polyclinics in Moscow and the Moscow region)]. Revmatologiia (Mosk) (1990) 0.75
[The place of rheumatic diseases in the pathology of the population of the Russian Federation]. Ter Arkh (1994) 0.75
[Antiviral immunity in families of patients with systemic lupus erythematosus and in medical personnel in contact with sick patients]. Ter Arkh (1978) 0.75
[Mixed connective tissue disease]. Ter Arkh (1982) 0.75
[T-activin in multimodal treatment of systemic lupus erythematosus in children]. Pediatriia (1991) 0.75
[Subgroups of patients with systemic lupus erythematosus]. Ter Arkh (1989) 0.75
[Incidence rate of rheumatic diseases in Russian population: 10-year analysis]. Ter Arkh (2002) 0.75
[Significance of urine glycosaminoglycan determination for the characterization of pathological processes in systemic lupus erythematosus]. Ter Arkh (1981) 0.75
[Russian society and patients with rheumatic diseases]. Vestn Ross Akad Med Nauk (2003) 0.75
[Autoimmunization: new facts, controversial questions and study prospects]. Ter Arkh (1991) 0.75
[Cortical-cell thymomas with predominance of so-called nurse-cells in patients with myasthenia]. Arkh Patol (1991) 0.75
[Role of HLA antigens in systemic lupus erythematosus]. Ter Arkh (1985) 0.75
[Rheumatic diseases in the light of international statistic classification of diseases and health problems (10th revision)]. Ter Arkh (1998) 0.75
[Results and prospects of studies of the physiology, morphology and pathology of the thymus gland]. Klin Med (Mosk) (1986) 0.75
[Thymus hyperplasia: classification, problems of patho- and morphogenesis, importance in human pathology]. Arkh Patol (1991) 0.75
[Autoimmune thyroiditis: pathogenesis, morphogenesis and classification]. Arkh Patol (1993) 0.75
[Lesions of the pulmonary vessels in patients with systemic lupus erythematosus]. Revmatologiia (Mosk) (1984) 0.75
[Clinico-morphological characteristics of thymomegaly]. Arkh Patol (1985) 0.75
[Clinico-immunological features of generalized myasthenia in patients with hyperplasia and atrophy of the thymus gland]. Klin Med (Mosk) (1991) 0.75
[Pathohistological diagnosis of precancerous conditions and cancer of the breast]. Arkh Patol (2001) 0.75
[The role of Pathology Department of the I.M. Sechenov Moscow Medical Academy in the development of forensic medicine]. Arkh Patol (2000) 0.75
[Systemic lupus erythomatosus]. Med Sestra (1978) 0.75
[Lymphocytotoxic and antibrain antibodies in patients with systemic lupus erythematosus with nervous system involvement]. Ter Arkh (1983) 0.75
[The status and prospects for the improvement of the rheumatology service]. Ter Arkh (1991) 0.75
[Statistics on rheumatic conditions in the Russian Federation in early 2000es]. Ter Arkh (2009) 0.75
[Detection of immunomodulating polypeptides in human thymus cells by an immunofluorescent method]. Biull Eksp Biol Med (1987) 0.75
[Exocrine function of the pancreas in patients with chronic hepatitis and liver cirrhosis of various etiologies]. Klin Med (Mosk) (1993) 0.75
[Methylprednisolone shock dose therapy of systemic lupus erythematosus with central nervous system involvement]. Vopr Revm (1982) 0.75
[Clinico-morphological characteristics of status thymicolymphaticus in adolescents and adults]. Arkh Patol (1983) 0.75
[Determination of antilymphocytic antibodies in systemic lupus erythematosus by indirect immunofluorescence technic using fixed lymphocytes]. Ter Arkh (1979) 0.75
[Ligament ruptures in systemic lupus erythematosus patients]. Ter Arkh (1984) 0.75
[Gigantomastia in pregnancy developing in a case of status thymicolymphaticus]. Arkh Patol (1984) 0.75
[Diagnosis and surgical treatment of myasthenia gravis in childhood]. Khirurgiia (Mosk) (1991) 0.75
[Dynamics of the basic statistical indices in rheumatic diseases]. Revmatologiia (Mosk) (1990) 0.75
[The importance of HLA antigens for the prognosis of the course and effect of treatment in systemic lupus erythematosus]. Vutr Boles (1988) 0.75
[The morphological and clinico-immunological characteristics of 2 types of myasthenia]. Arkh Patol (1991) 0.75
[Splenectomy in the treatment of severe generalized myasthenia gravis (first experience)]. Khirurgiia (Mosk) (1990) 0.75
[Metaplasia and dysplasia of thymus gland epithelium]. Arkh Patol (1996) 0.75
[Systemic lupus erythematosus among adolescents]. Klin Med (Mosk) (1986) 0.75
[Causes of death in patients with rheumatic diseases in Moscow]. Ter Arkh (2005) 0.75
[Thymomas with a myasthenic syndrome]. Khirurgiia (Mosk) (1998) 0.75
[Analysis of fatal outcomes according to the Moscow pathology service data (1996-2000)]. Arkh Patol (2001) 0.75
[Study of functional activity in rheumatoid arthritis]. Revmatologiia (Mosk) (1989) 0.75